Bimekizumab Impact on Core Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Domains for Patients with Psoriatic Arthritis: 52-Week Results from Four Phase 3 Studies

被引：0
|
作者：
Merola, Joseph [1 ]
Mease, Philip J. [2 ,3 ]
Deodhar, Atul [4 ]
Ink, Barbara [5 ]
Fleurinck, Carmen [6 ]
Bajracharya, Rajan [5 ]
Coarse, Jason [7 ]
Coates, Laura [8 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Newton, MA USA
[2] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR USA
[5] UCB Pharma, Slough, Berks, England
[6] UCB Pharma, Oosterzele, Belgium
[7] UCB Pharma, Morrisville, NC USA
[8] Univ Oxford, Oxford, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
DOUBLE-BLIND; TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1433
引用
收藏
页码：2819 / 2823
页数：5
相关论文
共 50 条
  • [21] Prologue: 2014 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
    Boehncke, Wolf-Henning
    Gladman, Dafna D.
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 1011 - 1013
  • [22] Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
    Kavanaugh, Arthur
    Mease, Philip J.
    Gomez-Reino, Juan J.
    Adebajo, Adewale O.
    Wollenhaupt, Juergen
    Gladman, Dafna D.
    Hochfeld, Marla
    Teng, Lichen L.
    Schett, Georg
    Lespessailles, Eric
    Hall, Stephen
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (03) : 479 - 488
  • [23] SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES
    Poddubnyy, D.
    Gensler, L. S.
    Mease, P. J.
    Orbai, A. M.
    Warren, R. B.
    Ink, B.
    Massow, U.
    Assudani, D.
    Fleurinck, C.
    Shende, V.
    Smith, J.
    Peterson, L.
    White, K.
    Landewe, R. B. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1686 - 1687
  • [24] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Thaci, Diamant
    Gottlieb, Alice B.
    Asahina, Akihiko
    Lebwohl, Mark
    McInnes, Iain B.
    Warren, Richard
    Boehncke, Wolf-Henning
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph F.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [25] Group for research and assessment of psoriasis and psoriatic arthritis-international multi-center psoriasis and psoriatic arthritis reliability trial (GRAPPA-IMPART): Assessment of psoriasis, nail lesions, peripheral arthritis, and dactylitis
    Gottlieb, Alice
    Cook, Richard
    Rosen, Cheryl
    Garg, Amit
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB123 - AB123
  • [26] Bimekizumab efficacy and safety in biologic bDMARD-naive patients with psoriatic arthritis was consistent with or without methotrexate: 52-week results from the phase 3 active reference study BE OPTIMAL
    McInnes, I.
    Mease, P.
    Tanaka, Y.
    Behrens, F.
    Gossec, L.
    Husni, M.
    Kristensen, L.
    Warren, R.
    Ink, B.
    Bajracharya, R.
    Coarse, J.
    Eells, J.
    Gottlieb, A.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 78 - 81
  • [27] ULTRASOUND DEMONSTRATES CONTINUED IMPROVEMENT IN PSORIATIC ARTHRITIS SYNOVITIS AND ENTHESITIS WITH SECUKINUMAB: 52-WEEK RESULTS FROM A PHASE 3 STUDY
    Conaghan, Philip G.
    D'Agostino, Maria A.
    Schett, Georg
    Guerrero, Carlos
    Hanova, Petra
    Cazenave, Tomas
    Stoenoiu, Maria S.
    Backhaus, Marina
    Mouterde, Gael
    Boers, Maarten
    Duggan, Anne-Marie
    Goyanka, Punit
    Gaillez, Corine
    [J]. RHEUMATOLOGY, 2022, 61 : I139 - I139
  • [28] 52-Week Efficacy and Safety Results from SPIRIT-P1: A Phase 3 Study of Ixekizumab in Patients with Active Psoriatic Arthritis
    Mease, Philip
    Okada, Masan
    Kishimoto, Mitsumasa
    Shuler, Catherine
    Carlier, Hilde
    Lin, Chen-Yen
    Mou, Jiani
    Moriarty, Susan
    Lee, Chin
    Gladman, Dafna
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 925 - 925
  • [29] Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
    Poddubnyy, Denis
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Braun, Jurgen
    Coates, Laura C.
    Chandran, Vinod
    Diekhoff, Torsten
    van Gaalen, Floris A.
    Gensler, Lianne S.
    Goel, Niti
    Gottlieb, Alice B.
    van der Heijde, Desiree
    Helliwell, Philip S.
    Hermann, Kay Geert A.
    Jadon, Deepak
    Lambert, Robert G.
    Maksymowych, Walter P.
    Mease, Philip
    Nash, Peter
    Proft, Fabian
    Protopopov, Mikhail
    Sieper, Joachim
    Torgutalp, Murat
    Gladman, Dafna D.
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [30] Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from a Phase 3 Study
    Mease, Philip J.
    Okada, Masato
    Kishimoto, Mitsumasa
    Shuler, Catherine L.
    Carlier, Hilde
    Lin, Chen-Yen
    Mou, Jiani
    Moriarty, Susan R.
    Lee, Chin H.
    Gladman, Dafna D.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345